NEUREN PHARMACEUT. ORDINARY (NEU) Short Interest
NEUREN PHARMACEUT. ORDINARY (ASX:NEU) had 6.02% of shares reported as short positions as of 16 May 2026, representing 7,613,587 shares. NEUREN PHARMACEUT. ORDINARY operates in the Pharmaceuticals, Biotechnology & Life Sciences industry. Source: ASIC short position report (T+4 delay).
- Short interest
- 6.02%
- Reported positions
- 7,613,587
- Industry
- Pharmaceuticals, Biotechnology & Life Sciences
- As of
- 16 May 2026
Source: official ASIC short position report, T+4 delay. Methodology · Disclaimer — not financial advice.
NEU
Neuren Pharmaceuticals
Neuren Pharmaceuticals is a biopharmaceutical company focused on developing therapies for neurological conditions. The company is positioned in the biotechnology sector, leveraging its expertise in neuroscience to address unmet medical needs. Neuren's unique value lies in its targeted approach to treating rare neurological disorders, with a strong pipeline of innovative products.